Cargando…

Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020

Steatosis is the hepatic manifestation of metabolic syndrome (MetS) and its developing is closely associated with insulin resistance. Shortened sleep has adverse effects on hepatic steatosis and the underlying mechanism remains unknown. We conceived to evaluate whether sleep duration was a lifestyle...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Junyan, Qiu, Weihong, Lin, Yuwei, Liu, Tianyu, Dou, Zulin, Chen, Zhaocong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511803/
https://www.ncbi.nlm.nih.gov/pubmed/37744738
http://dx.doi.org/10.1016/j.pmedr.2023.102406
_version_ 1785108222720344064
author Cao, Junyan
Qiu, Weihong
Lin, Yuwei
Liu, Tianyu
Dou, Zulin
Chen, Zhaocong
author_facet Cao, Junyan
Qiu, Weihong
Lin, Yuwei
Liu, Tianyu
Dou, Zulin
Chen, Zhaocong
author_sort Cao, Junyan
collection PubMed
description Steatosis is the hepatic manifestation of metabolic syndrome (MetS) and its developing is closely associated with insulin resistance. Shortened sleep has adverse effects on hepatic steatosis and the underlying mechanism remains unknown. We conceived to evaluate whether sleep duration was a lifestyle factor modifying the association between insulin resistance and hepatic steatosis and whether it was varied in different status of metabolic disturbances. We performed a cross-sectional analysis on 2264 adults of United States representing a population of 138,319,512 with MetS or pre-MetS from National Health and Nutrition Examination Survey (NHANES) 2017-March 2020. Participants underwent hepatic transient elastography and laboratory tests. The sleep duration was obtained from interviews. Results showed that insulin resistance was significantly associated with hepatic steatosis among participants with metabolic disturbances (OR = 1.85, 95% CI: 1.30–2.65). Significant moderation of sleep duration on the association between insulin resistance and hepatic steatosis was observed when sleep duration was dichotomized by 6.5- (P = 0.042) or 9.5-hour (P = 0.031). The risk of hepatic steatosis associated with insulin resistance was increased when sleep duration was ≤ 6.5 h and > 9.5 h. Furthermore, the moderation effect of 6.5-hour sleeping was only significant among participants with pre-MetS while that of 9.5-hour sleeping was only significant among participants with MetS. In conclusion, insufficient or excessive sleep increased the risk of hepatic steatosis associated with insulin resistance. Appropriate sleep duration was advocated and varied in different status of metabolic disturbances. Ensuring adequate sleep should be highlighted before MetS occurs and excessive sleep should be prevented for participants with MetS.
format Online
Article
Text
id pubmed-10511803
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-105118032023-09-22 Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020 Cao, Junyan Qiu, Weihong Lin, Yuwei Liu, Tianyu Dou, Zulin Chen, Zhaocong Prev Med Rep Regular Article Steatosis is the hepatic manifestation of metabolic syndrome (MetS) and its developing is closely associated with insulin resistance. Shortened sleep has adverse effects on hepatic steatosis and the underlying mechanism remains unknown. We conceived to evaluate whether sleep duration was a lifestyle factor modifying the association between insulin resistance and hepatic steatosis and whether it was varied in different status of metabolic disturbances. We performed a cross-sectional analysis on 2264 adults of United States representing a population of 138,319,512 with MetS or pre-MetS from National Health and Nutrition Examination Survey (NHANES) 2017-March 2020. Participants underwent hepatic transient elastography and laboratory tests. The sleep duration was obtained from interviews. Results showed that insulin resistance was significantly associated with hepatic steatosis among participants with metabolic disturbances (OR = 1.85, 95% CI: 1.30–2.65). Significant moderation of sleep duration on the association between insulin resistance and hepatic steatosis was observed when sleep duration was dichotomized by 6.5- (P = 0.042) or 9.5-hour (P = 0.031). The risk of hepatic steatosis associated with insulin resistance was increased when sleep duration was ≤ 6.5 h and > 9.5 h. Furthermore, the moderation effect of 6.5-hour sleeping was only significant among participants with pre-MetS while that of 9.5-hour sleeping was only significant among participants with MetS. In conclusion, insufficient or excessive sleep increased the risk of hepatic steatosis associated with insulin resistance. Appropriate sleep duration was advocated and varied in different status of metabolic disturbances. Ensuring adequate sleep should be highlighted before MetS occurs and excessive sleep should be prevented for participants with MetS. 2023-09-09 /pmc/articles/PMC10511803/ /pubmed/37744738 http://dx.doi.org/10.1016/j.pmedr.2023.102406 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Cao, Junyan
Qiu, Weihong
Lin, Yuwei
Liu, Tianyu
Dou, Zulin
Chen, Zhaocong
Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title_full Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title_fullStr Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title_full_unstemmed Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title_short Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020
title_sort appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the united states, nhanes 2017-march 2020
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511803/
https://www.ncbi.nlm.nih.gov/pubmed/37744738
http://dx.doi.org/10.1016/j.pmedr.2023.102406
work_keys_str_mv AT caojunyan appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020
AT qiuweihong appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020
AT linyuwei appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020
AT liutianyu appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020
AT douzulin appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020
AT chenzhaocong appropriatesleepdurationmodifyingtheassociationofinsulinresistanceandhepaticsteatosisisvariedindifferentstatusofmetabolicdisturbancesamongadultsfromtheunitedstatesnhanes2017march2020